معرفی
Paul Townsend is a Professor of Molecular Cell Biology at the University of Manchester, holding positions as Principal Investigator, Associate Dean of Business Engagement, and co-Director of the Manchester Centre for Cellular Metabolism. He leads applied research collaborations involving NHS, industry, and international partners, contributing to successful funding programs and cost-effective research initiatives. His work spans biomarker/drug discovery, cancer biology, and translational models for stress responses in cells and tissues.
- Bachelor of Science in Molecular Cell Biology (University of York, 1993)
- PhD in Biochemistry from Imperial Cancer Research Fund (1997)
- Postdoctoral training at Imperial College London, Southampton, and University College London
Research focuses on chemoresistance mechanisms, DNA damage, and apoptosis regulation using models like skeletal cells and cardiac myocytes. His lab includes 8 PhD students and 1 postdoc, with co-supervision of 2 additional PhD candidates. He lectures on cancer cell biology, proteomics, and systems biology.
Recent articles highlight advancements in prostate cancer proteomics, breast cancer therapy outcomes, and maternal diet impacts on childhood bone health. His work contributes to UN SDGs related to health and well-being.
He leads the Manchester Cancer Research Centre and holds adjunct roles at the University of Athens and Singapore's A*STAR. External roles include co-founding PRECignature and Pentagon Biotechnology, and advisory roles at multiple biotech firms.
